Peter de Nully Brown

Peter de Nully Brown

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
1 - 10 out of 10Page size: 500
  1. 2022
  2. Published

    Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy

    Baech, J., Severinsen, M. T., Øvlisen, A. K., Frederiksen, H., Vestergaard, P., Torp-Pedersen, Christian, Jørgensen, J., Clausen, M. R., Poulsen, Christian Bjørn, Brown, Peter de Nully, Gang, Anne Ortved, Pedersen, R. S., Smedby, K. E., Eloranta, S., Jakobsen, L. H. & El-Galaly, T. C., 2022, In: Blood advances. 6, 15, p. 4427-4435

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    NK- and T-cell lymphoma of the nasal cavity and paranasal sinuses in Denmark 1980-2017: a nationwide cohort study

    Eriksen, P. R. G., Clasen-Linde, E., Brown, Peter de Nully, Haunstrup, L., Christoffersen, M., Asdahl, P., Thomsen, T. M., von Buchwald, Christian & Heegaard, Steffen, 2022, In: Leukemia and Lymphoma. 63, 11, p. 2579-2588 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Sinonasal B-cell lymphomas: A nationwide cohort study, with an emphasis on the prognosis and the recurrence pattern of primary diffuse large B-cell lymphoma

    Eriksen, P. R. G., Clasen-Linde, E., Brown, Peter de Nully, Haunstrup, L., Christoffersen, M., Asdahl, P., Thomsen, T. M., Harwood, C. D., Heegaard, Steffen & von Buchwald, Christian, 2022, In: Hematological Oncology. 40, 2, p. 160-171

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial

    Fjordén, K., Ekberg, S., Kuric, N., Smedby, K. E., Lagerlöf, I., Larsen, T. S., Jørgensen, J. M., Brown, Peter de Nully & Jerkeman, M., 2022, In: British Journal of Haematology. 196, 2, p. 437-440 4 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  6. Published

    Level of unique T cell clonotypes is associated with clonal hematopoiesis and survival in patients with lymphoma undergoing ASCT

    Husby, Simon, Jørgensen, G. Ø., Favero, Francesco, Jespersen, Jakob Schmidt, Rodriguez Gonzalez, Francisco G, Nielsen, C., Sorensen, B., Ebbesen, L. H., Bæch, J., Haastrup, E. K., Josefsson, P., Thorsgaard, M., Brown, Peter de Nully, El-Galaly, T. C., Larsen, T. S., Weischenfeldt, Joachim Lütken & Grønbæk, Kirsten, 2022, In: Bone Marrow Transplantation. 57, p. 674-677

    Research output: Contribution to journal › Letter › Research › peer-review

  7. Published

    Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

    Meriranta, L., Alkodsi, A., Pasanen, A., Lepistö, M., Mapar, P., Blaker, Y. N., Jørgensen, J., Karjalainen-Lindsberg, M. L., Fiskvik, I., Mikalsen, L. T. G., Autio, M., Björkholm, M., Jerkeman, M., Fluge, Ø., Brown, Peter de Nully, Jyrkkiö, S., Holte, H., Pitkänen, E., Ellonen, P. & Leppä, S., 2022, In: Blood. 139, 12, p. 1863-1877 15 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Patterns of relapse and long-term outcome in patients treated with a curative intent for advanced Hodgkin lymphoma

    Nielsen, K., Maraldo, M. V., Berthelsen, A. K., Loft, A., Brown, Peter de Nully, Vogelius, I. R., Petersen, P. M. & Specht, Lena, 2022, In: Acta Oncologica. 61, 9, p. 1056-1063 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

    Nowakowski, G. S., Willenbacher, W., Greil, R., Larsen, T. S., Patel, K., Jäger, U., Manges, R. F., Trümper, L., Everaus, H., Kalakonda, N., Brown, Peter de Nully, Jørgensen, J. M., Cunningham, D., Dell’Aringa, J., Fox, B., Rubio, N. D., Kilavuz, N., Casadebaig, M. L., Manzke, O. & Munoz, J., 2022, In: International Journal of Hematology. 115, 2, p. 222-232

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors

    Salz, T., Zabor, E. C., Brown, Peter de Nully, Dalton, Susanne Oksbjerg, Raghunathan, N. J., Matasar, M. J., Steingart, R., Hjalgrim, Henrik, Specht, Lena, Vickers, A. J., Oeffinger, K. C. & Johansen, Christoffer, 2022, In: Acta Oncologica. 61, 9, p. 1064-1068

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Mental health among patients with non-Hodgkin lymphoma: A Danish nationwide study of psychotropic drug use in 8750 patients and 43 750 matched comparators

    Øvlisen, A. K., Jakobsen, L. H., Kragholm, K. H., Nielsen, R. E., Brown, Peter de Nully, Dahl-Sørensen, R. B., Frederiksen, H., Mannering, N., Josefsson, P. L., Ludvigsen Al-Mashhadi, A., Jørgensen, J. M., Dessau-Arp, A., Clausen, M. R., Pedersen, R. S., Torp-Pedersen, Christian, Severinsen, M. T. & El-Galaly, T. C., 2022, In: American Journal of Hematology. 97, 6, p. 749-761

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 165119349